Cadila Pharmaceuticals has launched Polycap – a combination of three common antihypertensive drugs along with aspirin and a statin, it has emerged.
Shri Modi, chairman of Cadila Pharmaceuticals, a leading Indian pharmaceutical company which has 400 multi-dimensional product formulations, said that Polycap has been tested in more than 2,000 patients in 50 centres in India by clinical researcher Dr Salim Yusuf from McMaster University Canada.
According to a study published in the Lancet, the drug lowered a number of risk factors associated with cardiovascular diseases, such as reducing blood pressure and heart rate.
Mr Modi explained that a standard patient of heart diseases needs to take over five or six pills of different medications each day.
He said the task of creating one pill of five drugs that work in five different ways was difficult.
"Pills have coatings and other ingredients that control the rate at which the medicine is released into the bloodstream," he said.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment